Monosodium urate microcrystals induce cyclooxygenase-2 in human monocytes

Blood

Volumn 91, Issue 5, 1998, Pages 1769-1776

  Pouliot, Marc ^a   James, Michael J ^b   McColl, Shaun R ^b   Naccache, Paul H ^b   Cleland, Leslie G ^b  

^a LAVAL UNIVERSITY   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HERBIMYCIN A; PROSTAGLANDIN SYNTHASE; URATE;

ARTICLE; CRYSTAL STRUCTURE; ENZYME INDUCTION; GOUT; HOUSEKEEPING GENE; HUMAN; HUMAN CELL; MEDIATOR RELEASE; MONOCYTE; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; TRANSLATION REGULATION;

EID: 0032031451     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.5.1769     Document Type: Article

References (54)

1. Faires JS, McCarty DJ: Acute arthritis in man and dog after synovial injection of sodium urate crystals. Lancet 2:682, 1962
2. Seegmiller JE, Howell RR, Malawista SE: The inflammatory reaction to sodium urate. J Am Med Assoc 180:125, 1962
3. Gordon TP, Terkeltaub RA, Ginsberg MH: Gout: Crystal-induced inflammation, in Gallin JI, Goldstein IM, Snyderman R (eds): Inflammation: Basic Principles and Clinical Correlates. New York, NY, Raven, 1988, p 775
4. Terkeltaub RA, Zachariae C, Santoro D, Martin J, Peveri P, Matsushima K: Monocyte-derived neutrophil chemotactic factor/interleukin-8 is a potential mediator of crystal-induced inflammation. Arthritis Rheum 34:894, 1991
5. Duff GW, Atkins E, Malawista SE: The fever of gout: urate crystals activate endogenous pyrogen production from human and rabbit mononuclear phagocytes. Trans Assoc Am Physicians 96:234, 1983
6. Dayer J-M, Evêquoz V, Zavadil-Grob C, Grynpas MD, Cheng P, Schnyder J, Trechsel V, Fleish H: Effect of synthetic calcium pyrophosphate and hydroxyapatite crystals on the interaction of human mononuclear cells with chondrocytes, synovial cells, and fibroblasts. Arthritis Rheum 30:1372, 1987
7. Guerne PA, Terkeltaub RA, Zuraw B, Lotz M: Inflammatory microcrystals stimulate interleukin-6 production and secretion by human monocytes and synoviocytes. Arthritis Rheum 32:1443, 1989
8. Di Giovine FS, Malawista SE, Thorton E, Duff GW: Urate crystals stimulate production of tumor necrosis factor alpha from human blood monocytes and synovial cells. J Clin Invest 78:1375, 1991
9. Woolf AD, Dieppe PA: Mediators of crystal-induced inflammation in the joint. Br Med Bull 43:429, 1987
10. Terkeltaub RA: Pathogenesis and treatment of crystal-induced inflammation, in McCarty DJ, Koopman WJ (eds): Arthritis and Allied Conditions, London, UK, Lea & Febiger, 1993, p 1819
11. 1 in urate crystal inflammation. J Rheumatol 1:222, 1974
12. Smith WL, Borgeat P, Fitzpatrick FA: The eicosanoids: Cyclooxygenase, lipoxygenase and epoxygenase pathways, in Vance DE, Vance J (eds): Biochemistry of Lipids, Lipoproteins and Membranes. New York, NY, Elsevier, 1991, p 297
13. Vane JR, Botting RM: Mechanism of action of anti-inflammatory drugs. Scand J Rheumatol 102:9, 1996
14. O'Banion MK, Sadowski HB, Winn V, Young DA: A serum- and glucocorticoid-regulated 4-kilobase mRNA encodes a cyclooxygenase-related protein. J Biol Chem 266:23261, 1991
15. Smith WL, Garavito RM, Dewitt DL: Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J Biol Chem 271:33157, 1996
16. Herschman HR: Prostaglandin synthase 2. Biochim Biophys Acta 1299:125, 1996
17. Williams CS, Dubois RN: Prostaglandin endoperoxide synthase - Why two isoforms. Am J Physiol 270:G393, 1996
18. O'Banion MK, Winn VD, Young DA: cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase. Proc Natl Acad Sci USA 89:4888, 1992
19. Seibert K, Zhang Y, Leahy K, Hauser S, Masferrer J, Perkins W, Lee L, Isakson P: Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc Natl Acad Sci USA 91:12013, 1994
20. 2 synthase (cyclooxygenase) in human monocytes. J Biol Chem 265:16737, 1990
21. Smallwood JI, Malawista SE: Colchicine, crystals, and neutrophil tyrosine phosphorylation. J Clin Invest 92:1602, 1993
22. Reiger MK, DeWitt DL, Schindler MS, Smith WL: Subcellular localization of prostaglandin endoperoxide synthase-2 in murine 3T3 cells. Arch Biochem Biophys 301:439, 1993
23. James MJ, Walsh JA: Inter-relationships between vascular thromboxane and prostacyclin synthesis. Prostagl Leukotr Essent Fatty Acids 31:91, 1988
24. Brown EH, Lehr JR, Smith JP, Frazier AW: Preparation and characterization of some calcium pyrophosphates. J Agric Food Chem 11:214, 1963
25. Denko CW, Whitehouse MW: Experimental inflammation induced by naturally occurring microcrystalline salts. J Rheumatol 3:54, 1976
26. Pouliot M, Baillargeon J, Lee JC, Cleland LG, James MJ: Inhibition of prostaglandin endoperoxide synthase-2 expression in stimulated human monocytes by inhibitors of a p38 mitogen-activated protein kinase. J Immunol 158:4930, 1997
27. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680, 1970
28. Akarasereenont P, Mitchell JA, Appleton I, Thiemermann C, Vane JR: Involvement of tyrosine kinase in the induction of cyclooxygenase and nitric oxide synthase by endotoxin in cultured cells. Br J Pharmacol 113:1522, 1994
29. Kester M, Coroneos E, Thomas PJ, Dunn MJ: Endothelin stimulates prostaglandin endoperoxide synthase-2 mRNA expression and protein synthesis through a tyrosine kinase-signaling pathway in rat mesengial cells. J Biol Chem 269:22574, 1994
30. Blanco A, Habib A, Levy-Toledano S, Maclouf J: Involvement of tyrosine kinases in the induction of cyclo-oxygenase-2 in human endothelial cells. Biochem J 312:419, 1995
31. Chanmugam P, Feng LL, Liou SE, Jang B, Boudreau M, Yu G, Lee JH, Kwon HJ, Beppu T, Yoshida M, Xia YY, Wilson CB, Hwang D: Radicicol, a protein tyrosine kinase inhibitor, suppresses the expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide and in experimental glomerulonephritis. J Biol Chem 270:5418, 1995
32. Akarasereenont P, Thiemermann C: The induction of cyclooxygenase-2 in human pulmonary epithelial cell culture (a549) activated by IL-1-beta is inhibited by tyrosine kinase inhibitors. Biochem Biophys Res Commun 220:181, 1996
33. Corbett JA, Kwon G, Marino MH, Rodi CP, Sullivan PM, Turk J, McDaniel ML: Tyrosine kinase inhibitors prevent cytokine-induced expression of iNOS and COX-2 by human islets. Am J Physiol 270:C1581, 1996
34. Noguchi K, Shitashige M, Yanai M, Morita I, Nishihara T, Murota S, Ishikawa I: Prostaglandin production via induction of cyclooxygenase-2 by human gingival fibroblasts stimulated with lipopolysaccharides. Inflammation 20:555, 1996
35. Tetsuka T, Srivastava SK, Morrison AR: Tyrosine kinase inhibitors, genistein and herbimycin a, do not block interleukin-1-beta-induced activation of nf-kappa-b in rat mesangial cells. Biochem Biophys Res Commun 218:808, 1996
36. Malawista SE, Duff GW, Atkins E, Cheung HS, McCarty DJ: Crystal-induced endogenous pyrogen production: A further look at gouty inflammation. Arthritis Rheum 28:1039, 1985
37. Lee JC, Badger AM, Griswold DE, Dunnington D, Truneh A, Votta B, White JR, Young PR, Bender PE: Bicyclic imidazoles as a novel class of cytokine biosynthesis inhibitors. Ann NY Acad Sci 696:149, 1993
38. Griswold DE, Hoffstein S, Marshall PJ, Webb EF, Bender PE, Hanna N: Inhibition of inflammatory cell infiltration by bicyclic imidazole, SK&F 86002 and SK&F 104493. Inflammation 13:727, 1989
39. Griswold DE, Hillegass LM, Meunier PC, DiMartino MJ, Hanna N: Effect of inhibitors of eicosanoid metabolism in murine collagen-induced arthritis. Arthritis Rheum 31:1406, 1988
40. Famaey JP: Colchicine in therapy. State of the art and new perspectives for an old drug. Clin Exp Rheumatol 6:305, 1988
41. Hartung EF: History of the use of colchicum and related medicaments in gout with suggestion for further research. Ann Rheum Dis 13:190, 1954
42. Olmsted JB, Borisy GG: Microtubules. Annu Rev Biochem 42:507, 1973
43. Zurier RB, Hoffstein S, Weissmann G: Cytochalasin B: Effect on lysosomal enzyme release from human leukocytes. Proc Natl Acad Sci USA 70:844, 1973
44. Goldstein I, Hoffstein S, Gallin J, Weissmann G: Mechanisms of lysosomal enzyme release from human leukocytes: microtubule assembly and membrane fusion induced by a component of complement. Proc Natl Acad Sci USA 70:2916, 1973
45. 4 by human neutrophils: the role of microtubules. J Immunol 136:1027, 1986
46. Ding A, Porteu F, Sanchez E, Nathan C: Downregulation of tumor necrosis factor receptors on macrophages and endothelial cells by microtubule depolymerizing agents. J Exp Med 171:715, 1990
47. Cronstein BN, Molad Y, Reibman J, Balakhane E, Levin RI, Weissmann G: Colchicine alters the quantitative and qualitative display of selectins on endothelial cells and neutrophils. J Clin Invest 96:994, 1995
48. Gaudry M, Roberge CJ, De Médicis R, Lussier A, Poubelle PE, Naccache PH: Crystal-induced neutrophil activation. 3. Inflammatory microcrystals induce a distinct pattern of tyrosine phosphorylation in human neutrophils. J Clin Invest 91:1649, 1993
49. Roberge CJ. Gaudry M, De Médicis R, Lussier A, Poubelle PE, Naccache PH: Crystal-induced neutrophil activation. 4. Specific inhibition of tyrosine phosphorylation by colchicine. J Clin Invest 92:1722, 1993
50. Denko CW: Anti-prostaglandin action of colchicine. Pharmacology 13:219, 1975
51. Spilberg I, Mandell B, Mehta J, Simchovitz L, Rosenberg D: Mechanism of action of colchicine in urate crystal-induced arthritis. J Clin Invest 64:775, 1979
52. Raud J, Dahlén SE, Sydbom A, Lindbom L, Hedqvist P: Enhancement of acute allergic inflammation by indomethacin is reversed by prostaglandin E2: Apparent correlation with in vivo modulation of mediator release. Proc Natl Acad Sci USA 85:2315, 1988
53. Serhan CN, Lundberg U, Weissman G, Samuelsson B: Formation of leukotrienes and hydroxy acids by human neutrophils and platelets exposed to monosodium urate. Prostaglandins 27:563, 1984
54. Otto JC, Dewitt DL, Smith WL: N-glycosylation of prostaglandin endoperoxide synthases-1 and synthases-2 and their orientations in their endoplasmic reticulum. J Biol Chem 268:18234, 1993